When developing new drugs, nutritional products, or pesticides, it’s critical that unknown molecules are identified correctly. But accurate identification is a lengthy process and all too often unsuccessful, leading to failed regulatory processes, or worse, consumer health being put in danger. Today, Isospec Analytics has raised $1.9M to commercialize new technologies for molecular analysis that rapidly identify unknown molecules in minutes, helping pharmaceuticals, nutrition and agritech companies develop safer products and enabling researchers to discover new biomarkers.Isospec’s $1.9M pre-seed round is led by Founderful (formerly Wingman Ventures), with additional participation from specialized investors Tiny.vc, another.vc and Venture Kick. Isospec was founded in 2022 by Ahmed Ben Faleh, Stephan Warnke, and Thomas Rizzo, who partnered together to explore how they could redefine the process of molecular analysis to access new biological information and enable breakthroughs in diagnostics, therapeutics, and nutrition.

在开发新药、营养产品或杀虫剂时，正确识别未知分子至关重要。但准确识别是一个漫长的过程，往往不成功，导致监管程序失败，或者更糟糕的是，消费者健康受到威胁。如今，Isospec Analytics已筹集190万美元，用于将分子分析新技术商业化，该技术可在几分钟内快速识别未知分子，帮助制药、营养和农业科技公司开发更安全的产品，并使研究人员能够发现新的生物标志物。Isospec价值190万美元的种子前一轮由Founderful（前身为Wingman Ventures）牵头，专业投资者Tiny.vc、another.vc和Venture Kick也参与了这一轮。Isospec由Ahmed Ben Faleh，Stephan Warnke和Thomas Rizzo于2022年成立，他们合作探索如何重新定义分子分析过程，以获取新的生物信息，并在诊断，治疗和营养方面取得突破。

Based on over 20 years of research, the founders combined technologies from multiple disciplines – analytical chemistry, photonics, and cryogenic materials initially designed for space applications – to build a tool that can generate a new data dimension about molecular structures. This allows for the identification of molecules which were, until now, unknown. Today, identifying an unknown molecule is primarily based on mass analysis, which does not provide sufficient information.

基于20多年的研究，创始人们结合了多个学科的技术——分析化学、光子学和最初为空间应用而设计的低温材料——来构建一种可以生成有关分子结构的新数据维度的工具。这允许鉴定到目前为止未知的分子。今天，鉴定未知分子主要基于质量分析，而质量分析不能提供足够的信息。

Identifying a by-product or an impurity requires the combination of high sensitivity to detect trace amounts in a sample, coupled with the ability to generate data that can definitively identify the structure of a molecule. Existing tools lack either one or both of these capabi.

鉴定副产物或杂质需要结合高灵敏度来检测样品中的痕量，再加上产生可以确定分子结构的数据的能力。现有工具缺少这两种capabi中的一种或两种。